JP2007523089A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007523089A5 JP2007523089A5 JP2006553342A JP2006553342A JP2007523089A5 JP 2007523089 A5 JP2007523089 A5 JP 2007523089A5 JP 2006553342 A JP2006553342 A JP 2006553342A JP 2006553342 A JP2006553342 A JP 2006553342A JP 2007523089 A5 JP2007523089 A5 JP 2007523089A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- nucleic acid
- binding
- antagonist
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54573004P | 2004-02-17 | 2004-02-17 | |
| US60/545,730 | 2004-02-17 | ||
| PCT/US2005/004743 WO2005079844A2 (en) | 2004-02-17 | 2005-02-15 | Use for interleukin-33 (il33) and the il-33 receptor complex |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011131646A Division JP2011178810A (ja) | 2004-02-17 | 2011-06-13 | インターロイキン−33(il33)およびil−33レセプター複合体の使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007523089A JP2007523089A (ja) | 2007-08-16 |
| JP2007523089A5 true JP2007523089A5 (cg-RX-API-DMAC7.html) | 2008-03-21 |
| JP4949859B2 JP4949859B2 (ja) | 2012-06-13 |
Family
ID=34886190
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006553342A Expired - Lifetime JP4949859B2 (ja) | 2004-02-17 | 2005-02-15 | インターロイキン−33(il33)およびil−33レセプター複合体の使用 |
| JP2011131646A Pending JP2011178810A (ja) | 2004-02-17 | 2011-06-13 | インターロイキン−33(il33)およびil−33レセプター複合体の使用 |
| JP2014030239A Pending JP2014098026A (ja) | 2004-02-17 | 2014-02-20 | インターロイキン−33(il33)およびil−33レセプター複合体の使用 |
| JP2015163939A Pending JP2016034948A (ja) | 2004-02-17 | 2015-08-21 | インターロイキン−33(il33)およびil−33レセプター複合体の使用 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011131646A Pending JP2011178810A (ja) | 2004-02-17 | 2011-06-13 | インターロイキン−33(il33)およびil−33レセプター複合体の使用 |
| JP2014030239A Pending JP2014098026A (ja) | 2004-02-17 | 2014-02-20 | インターロイキン−33(il33)およびil−33レセプター複合体の使用 |
| JP2015163939A Pending JP2016034948A (ja) | 2004-02-17 | 2015-08-21 | インターロイキン−33(il33)およびil−33レセプター複合体の使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (5) | US20050203046A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP1725261B1 (cg-RX-API-DMAC7.html) |
| JP (4) | JP4949859B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN1917902A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE496636T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2005215528B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0507808A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2555236C (cg-RX-API-DMAC7.html) |
| DE (1) | DE602005026105D1 (cg-RX-API-DMAC7.html) |
| NO (1) | NO20064193L (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ549040A (cg-RX-API-DMAC7.html) |
| TW (2) | TWI372628B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005079844A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200606844B (cg-RX-API-DMAC7.html) |
Families Citing this family (77)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002038794A2 (en) | 2000-11-09 | 2002-05-16 | The Brigham And Women's Hospital, Inc. | Cardiovascular disease diagnostic and therapeutic targets |
| ES2375181T3 (es) | 2002-05-09 | 2012-02-27 | The Brigham And Women's Hospital, Inc. | 1l 1rl-1 como un marcador de enfermedades cardiovasculares. |
| NZ549040A (en) | 2004-02-17 | 2009-07-31 | Schering Corp | Use for interleukin-33 (IL33) and the IL-33 receptor complex |
| JP2009511572A (ja) * | 2005-10-16 | 2009-03-19 | イエダ リサーチ アンド ディベロップメント カンパニー リミテッド | 炎症性皮膚疾患、障害または症状のための医薬組成物および診断方法 |
| PL2386860T4 (pl) * | 2006-04-24 | 2015-09-30 | Critical Care Diagnostics Inc | Przewidywanie śmiertelności i wykrywanie poważnej choroby |
| ATE517341T1 (de) * | 2006-04-27 | 2011-08-15 | Critical Care Diagnostics Inc | Interleukin-33 (il-33) zur diagnose und vorhersage von herz-gefäss-erkrankungen |
| DK2482078T3 (en) | 2006-05-01 | 2016-05-02 | Critical Care Diagnostics Inc | Cardiovascular disease diagnosis |
| SI2019965T1 (sl) * | 2006-05-02 | 2015-10-30 | Critical Care Diagnostics, Inc. | Diferencialna diagnoza med pljučno boleznijo in boleznijo srca in ožilja |
| WO2007130627A2 (en) * | 2006-05-04 | 2007-11-15 | The Brigham And Women's Hospital, Inc. | Il-33 in the treatment and diagnosis of diseases and disorders |
| US7560530B1 (en) | 2006-07-20 | 2009-07-14 | Schering Corporation | IL-33 receptor |
| SE532250C2 (sv) * | 2006-11-28 | 2009-11-24 | Theravac Pharmaceuticals Ab | Nya formuleringar av IL-33 för behandling av inflammatoriska tillstånd med en stark TH2 komponent genom vaccinering |
| US8119771B2 (en) | 2007-04-26 | 2012-02-21 | The Provost, Fellow and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | Products for altering IL-33 activity and methods thereof |
| JP2010527936A (ja) * | 2007-05-18 | 2010-08-19 | メディミューン,エルエルシー | 炎症性疾患におけるil−33 |
| PT3093663T (pt) | 2008-04-18 | 2018-10-19 | Critical Care Diagnostics Inc | Previsão do risco de eventos cardíacos adversos maiores |
| JP5539660B2 (ja) * | 2009-03-10 | 2014-07-02 | 公益財団法人ヒューマンサイエンス振興財団 | 粘膜ワクチン用アジュバント |
| EP2475388B1 (en) * | 2009-09-10 | 2017-11-08 | Merck Sharp & Dohme Corp. | Use of il-33 antagonists to treat fibrotic disease |
| ES2549637T3 (es) * | 2011-02-23 | 2015-10-30 | F. Hoffmann-La Roche Ag | Anticuerpos contra IL33R humano y la utilización de los mismos |
| FR2972006B1 (fr) | 2011-02-24 | 2016-03-25 | Centre Nat Rech Scient | Nouveaux fragments d'il-33 superactifs et leurs utilisations |
| CN103718046B (zh) | 2011-03-17 | 2016-10-12 | 重症监护诊断股份有限公司 | 预测不良临床结果的风险的方法 |
| US9212227B2 (en) | 2012-04-30 | 2015-12-15 | Janssen Biotech, Inc. | ST2L antibody antagonists for the treatment of ST2L-mediated inflammatory pulmonary conditions |
| AR091069A1 (es) | 2012-05-18 | 2014-12-30 | Amgen Inc | Proteinas de union a antigeno dirigidas contra el receptor st2 |
| IN2015DN01767A (cg-RX-API-DMAC7.html) | 2012-08-21 | 2015-05-29 | Critical Care Diagnostics Inc | |
| US10703799B2 (en) | 2012-12-10 | 2020-07-07 | Vib Vzw | IL-33R and IL-1RAcP fusion proteins |
| WO2014126277A1 (ko) * | 2013-02-14 | 2014-08-21 | 건국대학교 산학협력단 | 신규한 인터루킨-33 수용체와 결합 단백질 조성물 및 그 용도 |
| WO2014128254A1 (en) * | 2013-02-22 | 2014-08-28 | University Of Eastern Finland (Kuopion Kampus) | Il-33 and treatment of neurodegenerative diseases |
| JO3532B1 (ar) * | 2013-03-13 | 2020-07-05 | Regeneron Pharma | الأجسام المضادة لمضاد انترلوكين-33 واستعمالاتها |
| EP2968392B1 (en) | 2013-03-15 | 2020-08-05 | Elixirgen Therapeutics, Inc. | Methods of using zscan4 for rejuvenating human cells |
| JP6404314B2 (ja) | 2013-03-15 | 2018-10-10 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. | Il−33拮抗薬とその使用法 |
| US9840545B2 (en) | 2013-09-20 | 2017-12-12 | University Of Virginia Patent Foundation | Fusion protein comprising interleukin-2 and interleukin-33 |
| AU2014332352B9 (en) * | 2013-10-07 | 2017-05-11 | Inovio Pharmaceuticals, Inc. | Vaccines with Interleukin-33 as an adjuvant |
| HUE064292T2 (hu) | 2013-12-26 | 2024-03-28 | Mitsubishi Tanabe Pharma Corp | Humán anti-IL-33 semlegesítõ monoklonális antitest |
| SG11201605580RA (en) | 2014-01-10 | 2016-10-28 | Anaptysbio Inc | Antibodies directed against interleukin-33 (il-33) |
| WO2015143343A2 (en) | 2014-03-21 | 2015-09-24 | The Brigham And Women's Hospital, Inc. | Methods and compositions for treatment of immune-related diseases or disorders and/or therapy monitoring |
| CA2946511C (en) | 2014-04-21 | 2023-08-22 | The Childen's Hospital Of Philadelphia | Compositions and methods for treating cytokine-related disorders |
| JP6929771B2 (ja) | 2014-11-10 | 2021-09-01 | ジェネンテック, インコーポレイテッド | 抗インターロイキン−33抗体及びその使用 |
| US11708608B2 (en) | 2014-11-10 | 2023-07-25 | Genentech, Inc. | Therapeutic and diagnostic methods for IL-33-mediated disorders |
| WO2016140921A1 (en) | 2015-03-02 | 2016-09-09 | 180 Therapeutics Lp | Method of treating a localized fibrotic disorder using an il-33 antagonist |
| WO2016138590A1 (en) * | 2015-03-03 | 2016-09-09 | Wilfred Jefferies | Modulation of cancer immunity with type 2 innate lymphoid cells, interleukin 33, and/or interferon induced protein 44 |
| MX387295B (es) | 2015-03-31 | 2025-03-18 | Medimmune Ltd | Nueva forma de interleucina-33 (il33), formas mutadas de interleucina-33 (il33), anticuerpos, ensayos y métodos para usar los mismos. |
| JP6501650B2 (ja) * | 2015-06-25 | 2019-04-17 | 田辺三菱製薬株式会社 | ヒト抗il−33中和モノクローナル抗体 |
| US10813979B2 (en) * | 2015-07-10 | 2020-10-27 | The Hong Kong University Of Science And Technology | Methods and compositions for treating neurodegenerative and neuroinflammatory conditions |
| JP6858182B2 (ja) * | 2015-10-06 | 2021-04-14 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. | インターロイキン33(il−33)媒介疾患に関するバイオマーカーおよびその使用 |
| KR101765397B1 (ko) | 2015-12-02 | 2017-08-07 | 한국과학기술원 | 질점막을 통한 바이러스 감염 취약 진단 마커로서의 il-33의 용도 |
| SG11201808693WA (en) | 2016-04-27 | 2018-11-29 | Pfizer | Anti-il-33 antibodies, compositions, methods and uses thereof |
| JP7148414B2 (ja) | 2016-06-29 | 2022-10-05 | チェックポイント セラピューティクス,インコーポレイテッド | Pd-l1特異的抗体およびそれを使用する方法 |
| JOP20190093A1 (ar) * | 2016-10-28 | 2019-04-25 | Lilly Co Eli | أجسام مضادة لـ il-33 واستخداماتها |
| TWI784988B (zh) | 2016-12-01 | 2022-12-01 | 美商再生元醫藥公司 | 治療發炎症狀的方法 |
| CN116715775A (zh) | 2017-02-10 | 2023-09-08 | 豪夫迈·罗氏有限公司 | 抗类胰蛋白酶抗体、其组合物及其用途 |
| EP3582802A4 (en) * | 2017-02-17 | 2021-02-17 | The General Hospital Corporation | METHODS AND COMPOSITIONS FOR THE TREATMENT OF A BRAIN INJURY |
| MX2019012171A (es) | 2017-04-13 | 2019-11-25 | Regeneron Pharma | Tratamiento e inhibicion de enfermedades pulmonares inflamatorias en pacientes que tienen alelos de riesgo en los genes que codifican la il33 e il1rl1. |
| KR102872720B1 (ko) | 2017-05-05 | 2025-10-16 | 유니버시티 오브 피츠버그 - 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 | 기질 결합 소낭의 안구에의 적용 |
| WO2019045075A1 (ja) | 2017-08-31 | 2019-03-07 | 田辺三菱製薬株式会社 | Il-33アンタゴニストを含む子宮内膜症治療剤 |
| KR20220098056A (ko) | 2018-02-09 | 2022-07-08 | 제넨테크, 인크. | 비만 세포 매개 염증성 질환에 대한 치료 및 진단 방법 |
| IL307286B2 (en) | 2018-04-11 | 2026-03-01 | Regeneron Pharma | Methods and compositions for quantifying il-33 |
| EP3787642A4 (en) * | 2018-05-03 | 2022-09-21 | University of Pittsburgh - of the Commonwealth System of Higher Education | IL-33 CONTAINING MATRIX-BONDED VESICLES (MBVS) AND THEIR USE |
| CN112996805A (zh) | 2018-08-30 | 2021-06-18 | Hcw生物科技公司 | 多链嵌合多肽和其用途 |
| WO2020047333A1 (en) | 2018-08-30 | 2020-03-05 | HCW Biologics, Inc. | Single-chain chimeric polypeptides and uses thereof |
| CA3109139A1 (en) | 2018-08-30 | 2020-03-05 | HCW Biologics, Inc. | Methods of treating aging-related disorders |
| TWI861073B (zh) | 2019-03-21 | 2024-11-11 | 美商再生元醫藥公司 | 含有抗il-33抗體之穩定調配物 |
| AU2020294797B2 (en) | 2019-06-21 | 2025-12-18 | Immunitybio, Inc. | Multi-chain chimeric polypeptides and uses thereof |
| WO2021003138A1 (en) * | 2019-06-30 | 2021-01-07 | Memorial Sloan Kettering Cancer Center | Methods and compositions for treatment of pancreatic cancer |
| WO2021068196A1 (en) * | 2019-10-11 | 2021-04-15 | General Regeneratives (Shanghai) Limited | Methods of using il-33 protein in treating cancers |
| JP7843701B2 (ja) * | 2019-11-04 | 2026-04-10 | メディミューン リミテッド | Il-33アンタゴニストの使用方法 |
| CN116670163A (zh) | 2020-02-11 | 2023-08-29 | Hcw生物科技公司 | 治疗年龄相关疾病和炎性疾病的方法 |
| WO2021163299A1 (en) | 2020-02-11 | 2021-08-19 | HCW Biologics, Inc. | Chromatography resin and uses thereof |
| CA3169243A1 (en) | 2020-02-11 | 2021-08-19 | HCW Biologics, Inc. | Methods of activating regulatory t cells |
| EP4118114A1 (en) | 2020-03-13 | 2023-01-18 | Genentech, Inc. | Anti-interleukin-33 antibodies and uses thereof |
| AU2021262794B2 (en) | 2020-04-29 | 2026-06-18 | Immunitybio, Inc. | Anti-CD26 proteins and uses thereof |
| US12024545B2 (en) | 2020-06-01 | 2024-07-02 | HCW Biologics, Inc. | Methods of treating aging-related disorders |
| WO2021247003A1 (en) | 2020-06-01 | 2021-12-09 | HCW Biologics, Inc. | Methods of treating aging-related disorders |
| IL298608A (en) | 2020-06-01 | 2023-01-01 | Hcw Biologics Inc | Methods for treating disorders related to aging |
| CN112210556A (zh) * | 2020-10-15 | 2021-01-12 | 扬州大学 | 一组靶向干扰IL-33表达的shRNA、重组腺病毒载体及其构建方法和应用 |
| WO2022164976A2 (en) * | 2021-01-27 | 2022-08-04 | The Trustees Of Dartmouth College | Immunostimulatory cytokine combination and therapeutic use thereof |
| WO2023086807A1 (en) | 2021-11-10 | 2023-05-19 | Genentech, Inc. | Anti-interleukin-33 antibodies and uses thereof |
| CN114426981B (zh) * | 2022-02-21 | 2022-11-29 | 吉林农业大学 | 非洲猪瘟病毒抗原蛋白重组表达载体、重组植物乳酸菌及其制备方法和应用 |
| US12594323B2 (en) | 2022-04-13 | 2026-04-07 | Immunitybio, Inc. | Methods of reducing neuroinflammation |
| CN118185884A (zh) * | 2023-10-16 | 2024-06-14 | 王琪 | 负载il33的溶瘤痘苗病毒及其与免疫检查点抑制剂的联合疗法 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5116964A (en) * | 1989-02-23 | 1992-05-26 | Genentech, Inc. | Hybrid immunoglobulins |
| US6176962B1 (en) | 1990-02-28 | 2001-01-23 | Aclara Biosciences, Inc. | Methods for fabricating enclosed microchannel structures |
| WO1992010210A1 (en) * | 1990-12-14 | 1992-06-25 | E.I. Du Pont De Nemours And Company | Inhibition of angiogenesis by il-1 |
| US5856457A (en) | 1991-03-29 | 1999-01-05 | Genentech, Inc. | Nucleic acids encoding a human IL-8 receptor |
| WO1995001997A1 (en) | 1993-07-09 | 1995-01-19 | Smithkline Beecham Corporation | RECOMBINANT AND HUMANIZED IL-1β ANTIBODIES FOR TREATMENT OF IL-1 MEDIATED INFLAMMATORY DISORDERS IN MAN |
| US5576191A (en) * | 1994-06-17 | 1996-11-19 | Immunex Corporation | Cytokine that binds ST2 |
| US6132764A (en) | 1994-08-05 | 2000-10-17 | Targesome, Inc. | Targeted polymerized liposome diagnostic and treatment agents |
| US5888530A (en) | 1995-07-21 | 1999-03-30 | The General Hospital Corporation | Method of enhancing delivery of a pharmaceutical formulation |
| US6056973A (en) | 1996-10-11 | 2000-05-02 | Sequus Pharmaceuticals, Inc. | Therapeutic liposome composition and method of preparation |
| US5842787A (en) | 1997-10-09 | 1998-12-01 | Caliper Technologies Corporation | Microfluidic systems incorporating varied channel dimensions |
| ATE406441T1 (de) | 1997-10-29 | 2008-09-15 | Genentech Inc | Verwendung des wnt-1 induzierten sekretierten polypeptids wisp-1 |
| WO1999032626A1 (en) * | 1997-12-23 | 1999-07-01 | Immunex Corporation | Sigirr dna and polypeptides |
| GB9727172D0 (en) * | 1997-12-24 | 1998-02-25 | Univ Glasgow | Reagents specific for st2l and uses therefor |
| US6326482B1 (en) | 1999-04-23 | 2001-12-04 | Genentech, Inc. | SH2 domain-containing peptides |
| CA2340579A1 (en) | 1998-09-01 | 2000-03-09 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Interleukin 18-binding protein |
| WO2000032634A1 (en) | 1998-12-01 | 2000-06-08 | Protein Design Labs, Inc. | Humanized antibodies to gamma-interferon |
| US6323334B1 (en) * | 1999-09-24 | 2001-11-27 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules encoding a 103 gene product and uses therefor |
| WO2001046697A2 (en) | 1999-12-21 | 2001-06-28 | Millennium Predictive Medicine | Identification, assessment, prevention, and therapy of breast cancer |
| GB0020685D0 (en) | 2000-08-22 | 2000-10-11 | Novartis Ag | Organic compounds |
| CA2431861A1 (en) | 2000-12-08 | 2002-06-13 | Curagen Corporation | Method of detecting and treating tuberous sclerosis complex associated disorders |
| US20040009481A1 (en) * | 2001-06-11 | 2004-01-15 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of human prostate cancer |
| AU2002324700A1 (en) | 2001-08-14 | 2003-03-03 | Bayer Ag | Nucleic acid and amino acid sequences involved in pain |
| AU2001289843A1 (en) | 2001-08-28 | 2002-02-13 | Bayer Cropscience Ag | Polypeptides for identifying herbicidally active compounds |
| AU2003299441A1 (en) * | 2002-12-19 | 2004-07-14 | Centre National De La Recherche Scientifique - Cnrs | Nf-hev compositions and methods of use |
| EP1759010A4 (en) | 2004-01-07 | 2008-12-24 | Bristol Myers Squibb Co | BIOMARKERS AND METHOD FOR DETERMINING SENSITIVITY AGAINST MODULATORS OF EGF (EPIDERMAL GROWTH FACTOR) RECEPTORS |
| NZ549040A (en) | 2004-02-17 | 2009-07-31 | Schering Corp | Use for interleukin-33 (IL33) and the IL-33 receptor complex |
| US7560530B1 (en) | 2006-07-20 | 2009-07-14 | Schering Corporation | IL-33 receptor |
| JP2010527936A (ja) | 2007-05-18 | 2010-08-19 | メディミューン,エルエルシー | 炎症性疾患におけるil−33 |
-
2004
- 2004-11-29 NZ NZ549040A patent/NZ549040A/xx not_active IP Right Cessation
-
2005
- 2005-02-15 CA CA2555236A patent/CA2555236C/en not_active Expired - Lifetime
- 2005-02-15 JP JP2006553342A patent/JP4949859B2/ja not_active Expired - Lifetime
- 2005-02-15 EP EP05713577A patent/EP1725261B1/en not_active Expired - Lifetime
- 2005-02-15 AU AU2005215528A patent/AU2005215528B2/en not_active Ceased
- 2005-02-15 CN CNA2005800050705A patent/CN1917902A/zh active Pending
- 2005-02-15 AT AT05713577T patent/ATE496636T1/de not_active IP Right Cessation
- 2005-02-15 US US11/059,117 patent/US20050203046A1/en not_active Abandoned
- 2005-02-15 WO PCT/US2005/004743 patent/WO2005079844A2/en not_active Ceased
- 2005-02-15 EP EP10177117.8A patent/EP2283860A3/en not_active Withdrawn
- 2005-02-15 BR BRPI0507808-3A patent/BRPI0507808A/pt not_active IP Right Cessation
- 2005-02-15 DE DE602005026105T patent/DE602005026105D1/de not_active Expired - Lifetime
- 2005-02-16 TW TW094104561A patent/TWI372628B/zh not_active IP Right Cessation
- 2005-02-16 TW TW101117025A patent/TW201304802A/zh unknown
-
2006
- 2006-08-15 ZA ZA200606844A patent/ZA200606844B/xx unknown
- 2006-09-15 NO NO20064193A patent/NO20064193L/no not_active Application Discontinuation
-
2007
- 2007-03-05 US US11/682,224 patent/US20070160579A1/en not_active Abandoned
-
2008
- 2008-09-26 US US12/239,689 patent/US20090041718A1/en not_active Abandoned
-
2011
- 2011-06-13 JP JP2011131646A patent/JP2011178810A/ja active Pending
-
2014
- 2014-02-03 US US14/171,629 patent/US9970944B2/en active Active
- 2014-02-20 JP JP2014030239A patent/JP2014098026A/ja active Pending
-
2015
- 2015-08-21 JP JP2015163939A patent/JP2016034948A/ja active Pending
-
2017
- 2017-12-20 US US15/848,417 patent/US20180128837A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20260049993A1 (en) | Viral serology assays | |
| US20230204568A1 (en) | Measuring trail by lateral flow immunoassay | |
| US20210389308A1 (en) | Detecting adaptive immunity to coronavirus | |
| US20210405059A1 (en) | Biomarkers for early determination of a critical or life threatening response to illness and/or treatment response | |
| EP4141448A1 (en) | Protein signatures for distinguishing between bacterial and viral infections | |
| ES2683854T3 (es) | Un método para determinar biomarcadores relacionados con el síndrome de distrés respiratorio agudo (ARDS), un método para monitorizar el desarrollo y tratamiento de ARDS en un paciente | |
| AU2016210996B2 (en) | Therapeutic target and biomarker in IBD | |
| US8367350B2 (en) | Compositions and methods for diagnosis, prognosis and management of malaria | |
| Gupta et al. | Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments | |
| US20170234873A1 (en) | Signatures and determinants for diagnosing infections in non-human subjects and methods of use thereof | |
| EP4184167A1 (en) | Early diagnosis of infections | |
| WO2010025393A2 (en) | Protein biomarkers and methods for diagnosing kawasaki disease | |
| Desplat-Jégo et al. | Quantification of immunoglobulin free light chains in cerebrospinal fluid by nephelometry | |
| JP2007523088A5 (cg-RX-API-DMAC7.html) | ||
| EP3183582A2 (en) | Biomarkers for diagnosis and management of neuro-immunological diseases | |
| CN111133313A (zh) | 评估生物药物治疗的受试者中的中和性抗体水平的测定及其在个性化医疗中的用途 | |
| RU2018108831A (ru) | Биомаркеры для лечения очаговой алопеции | |
| CN102884433A (zh) | 用于检测抗体的方法 | |
| US20160231333A1 (en) | Biomarkers for Tuberculosis | |
| EP3289358A1 (en) | Novel design of enzyme-linked immunsorbent assay plates and systems and methods of use thereof | |
| CN105849566A (zh) | 肾脏疾病生物标志物 | |
| CN111954814A (zh) | 定量il-33的方法和组合物 | |
| WO2013114064A1 (en) | Methods and devices for diagnosis of serious bacterial infection | |
| WO2023034933A1 (en) | Methods and systems for assessing adaptive immunity to coronavirus | |
| EP3827098A1 (en) | Method of diagnosing asthma subtypes |